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Abstract Activin signals through a heteromeric complex of
receptor serine kinases by inducing type II receptor-mediated
phosphorylation, and consequent activation, of the type I
receptor. Type I receptor phosphorylation occurs at a glycine-
and serine-rich site in the juxtamembrane domain; phosphoryla-
tion at that site correlates with signaling. Investigation of type I
activin receptor mutants impaired for GS domain phosphoryla-
tion revealed that, in the presence of elevated amounts of type II
activin receptor, GS domain phosphorylation is not required for
signaling. The type I receptor showed activin-dependent phos-
phorylation of several tryptic phosphopeptides, suggesting that
phosphorylation of receptor I at sites both within and outside the
GS domain is required for full signaling.
z 1997 Federation of European Biochemical Societies.
Key words: Activin; Receptor serine kinase;
Protein phosphorylation
1. Introduction
The receptor serine kinase family contains two classes of
transmembrane protein serine kinases, the type I receptors
and the type II receptors [1]. Members of this family mediate
transmembrane signaling for activin, transforming growth
factor L (TGFL) and related factors, and are thought to act
by formation of a heterooligomeric complex containing both
type I and type II receptors. A current model for receptor
action posits that ligand binding induces the formation of a
type I:type II complex, resulting in type II receptor-mediated
activation of the type I receptor by phosphorylation at resi-
dues within a conserved glycine- and serine-rich domain in the
juxtamembrane region [2]. For activin [3,4] and TGFL [5] type
I receptors (ALK4 and TLRI, respectively), mutation to ala-
nine of the hydroxyamino acids in that GS domain yields
molecules which can no longer support ligand-dependent tran-
scriptional activation, implying that such phosphorylation is
required for normal signal transduction to occur. The mech-
anism through which modi¢cation of residues within the GS
domain enhances signaling by the type I receptors, either by
stimulation of intrinsic enzymatic activity or by recruitment of
intracellular signaling molecules, is not currently known.
In an earlier study of the ALK4 GS domain, we observed
that potential phosphorylation of some GS domain residues
was functionally more signi¢cant than others [3]. Speci¢cally,
certain mutants in which four out of ¢ve hydroxyamino acids
in the GS domain were changed to alanine retained signi¢cant
signaling capacity. In pursuing the correlation of phosphoryl-
ation with function, we have now found that under conditions
of type II activin receptor (ActR) overexpression, phosphoryl-
ation at the GS domain is not absolutely required to generate
an activin-dependent transcriptional response.
2. Materials and methods
2.1. Materials
Puri¢ed activin A was generously provided by Dr. Yuzuru Eto, and
by the National Hormone and Pituitary Program, the NIDDK,
NICHD, and USDA (lot 15365-36). D-Luciferin was obtained from
Sigma Chemical Co (St. Louis, MO). [32P]Orthophosphate (500 mCi/
ml) was obtained from ICN Pharmaceuticals (Irvine, CA). Activin
receptor (ActR) DNAs and p3TP-Lux were as described [3].
2.2. Luciferase assay
The L17 mink lung epithelial cell line [6] was cultured and trans-
fected as described [3]. For luciferase assays, L17 cells were plated at a
density of 2.5U104 cells per well in 24-well plates and grown over-
night before transfection. Cells were transfected with 0.5 Wg of the
p3TP-Lux reporter plasmid and combinations of ActR DNAs (0.1 Wg)
as indicated. Cells were co-transfected with 0.25 Wg of a plasmid ex-
pressing L-galactosidase. Following transfection, cells recovered for 30
h and were then stimulated with 2 nM activin A in 0.25 ml medium
containing 0.2% fetal bovine serum (v/v). Luciferase activity was
measured in 40 Wl of a 200 Wl lysate as described [3]. Luciferase
activity was normalized to L-galactosidase activity measured in 20
Wl of lysate as described [7]. The data in Figs. 1^3 show results
from single representative experiments; each experiment was repeated
at least three times.
2.3. Phosphorylation analysis
Cells plated in six-well dishes (approximately 2U105 cells per well)
were transfected with various receptor combinations and allowed to
recover in complete medium overnight. The transfected cells were
labeled with [32P]orthophosphate, and ALK4 proteins were immuno-
precipitated with anti-HA antibody [8] exactly as described [3]. Tryp-
tic phosphopeptide mapping and phosphoamino acid analysis were
performed exactly as described for ActRII [9,10].
3. Results and discussion
In a previous report [3] we noted that one of three tested
quadruple mutants of the ALK4 GS domain (ALK4-4A-S187,
in which serine 187 was the only one of the ¢ve serine or
threonine residues in the GS domain not mutated) had the
capacity to support activin responsiveness in receptor I-de¢-
cient cells (see Fig. 1). To follow up that observation, all ¢ve
quadruple mutants of ALK4 were prepared and tested for
their capacity to confer activin inducibility of the 3TP-Lux
reporter gene in L17 cells. In addition to ALK4-4A-S187,
ALK4-4A-S189 and ALK4-4A-S191 also mediated activin sig-
naling (Fig. 1). Interestingly, S187, S189 and S191 were the
only residues which when mutated in combination of three
rendered ALK4 inactive in this assay [3] (see Fig. 2, ATAAS),
consistent with the interpretation that phosphorylation of
those speci¢c residues is associated with signaling.
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We also showed previously that ALK4-ETEES (S187E,
S189E, S191E) had a signaling capacity similar to wild-type.
To determine whether that signaling was potentially due to
residual phosphorylation of the other residues in the GS do-
main, we prepared and tested ALK4-EAEEA, which also sig-
naled normally (Fig. 2). This result supports our earlier con-
clusion that acidic substitutions of speci¢c hydroxyamino
acids in the ALK4 GS domain can mimic functional phos-
phorylation; however, because basal signaling remained low
these data imply that additional activin-dependent regulation
of ALK4 is required for full activity (see below).
Because L17 cells express very low amounts of type II
ActRs as judged by ligand binding experiments (not shown),
we determined the e¡ect of overexpression of ActRIIB togeth-
er with di¡erent GS domain mutants. Fig. 3 shows represen-
tative results for a partially active quadruple mutant (4A-
S189), an inactive quadruple mutant (4A-S193), and the
non-phosphorylatable mutant ALK4-5A. Surprisingly, expres-
sion of elevated amounts of ActRIIB increased the activin
responsiveness conferred on the cells by all the ALK4 mutants
tested, including ALK4-5A. For 4A-S189, the change in acti-
vin induction was increased from 3^5 fold in the absence of
ActRIIB to 10^20 fold in the presence of ActRIIB; for 4A-
S193 and 5A, the corresponding induction went from approx-
imately 1.5 fold to 3^8 fold. As previously observed, over-
expression of ActRIIB alone neither a¡ected basal expression
of the reporter gene nor rendered the cells responsive to acti-
vin. Both ActRII and ActRIIB had this ALK4-potentiating
activity, while TLRII did not (not shown). The kinase activity
of ActRIIB was essential to bring about this rescue of ALK4
signaling, as an enzymatically inactive mutant (ActRIIB-
K217R) was unable to induce an activin response (Fig. 3).
It is possible that GS domain phosphorylation markedly
increases ALK4 activity, but that ALK4 mutants which are
not phosphorylated at the GS domain do have very low basal
signaling activity when complexed with type II receptors. Be-
cause receptor II is present only at very low amounts in L17
cells, that low amount of signaling is insu⁄cient to generate a
biological response from ALK4-5A. Quantitatively increasing
the number of receptor complexes formed ^ by overexpression
of ActRIIB ^ could thus lead to enough of an increase in the
number of weakly signaling ALK4-5A:ActRIIB complexes to
allow for a modest response to activin treatment. Given that
type II receptor kinase activity was required for this response,
the enhanced ALK4 activity is likely due to increased phos-
phorylation at a site(s) distinct from the GS domain.
To examine ALK4 phosphorylation, ALK4 and ALK4-5A
were transiently expressed in L17 cells together with ActRIIB,
metabolically labeled with [32P]orthophosphate, and analyzed
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Fig. 1. Signaling activity of ALK4 GS domain mutants. L17 cells
were transfected with 3TP-Lux together with di¡erent ALK4 con-
structs as indicated. Cells were treated with 2 nM activin A and
then luciferase and L-galactosidase activity were measured. The data
were normalized with L-galactosidase activity, and the level of luci-
ferase expression in the absence of exogenous receptors and the ab-
sence of activin set to one. Values were determined in triplicate and
represent the mean þ standard deviation. The data are representative
of several independent experiments.
Fig. 2. Replacement of ALK4 GS domain phosphorylation sites
with acidic amino acids. L17 cells were transfected with 3TP-Lux
together with the indicated ALK4 mutants. WT, wild-type GS do-
main sequence (STSGSGS, S187, T188, S189, S191, S193). Cells
were treated with activin and assayed as in Fig. 1.
Fig. 3. E¡ect of type II activin receptor on type I receptor signaling.
L17 cells were transfected with 3TP-Lux together with combinations
of di¡erent type I and type II receptor constructs as indicated. Cells
were treated with activin and assayed as in Fig. 1. WT, wild-type
ActRIIB; KR, ActRIIB-K217R, an enzymatically inactive point
mutant.
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by immunoprecipitation. Although both proteins were ex-
pressed in comparable amounts (not shown), ALK4 was
phosphorylated to a substantially greater extent than was
ALK4-5A in both the basal and ligand-activated states (Fig.
4A). The reduced phosphorylation observed in ALK4-5A is
consistent with the wild-type receptor undergoing modi¢ca-
tion at the GS domain. Phosphoamino acid analysis of those
samples revealed that ALK4 was phosphorylated primarily on
serine, with a minor component on threonine; phosphotyro-
sine was not detected (Fig. 4B). Phosphothreonine was not
detected in ALK4-5A, suggesting that T188 in the GS domain
is phosphorylated in the wild-type protein; curiously, T188 is
not one of the residues implicated by the mutagenic analysis
as required for signaling. As previously observed [3], activin
treatment resulted in a modest increase in ALK4 phosphoryl-
ation; an increase in phosphorylation of ALK4-5A was also
seen (Fig. 4A).
To visualize those phosphorylation sites, 32P-labeled pro-
teins were digested with trypsin and resolved in two dimen-
sions on thin-layer chromatography plates. For wild-type
ALK4, a number of novel tryptic phosphopeptides were de-
tected in the activin-treated sample that were not present in
the basal state (Fig. 4C). Although the identities of those
various peptides are not currently known, it is likely that
some of them represent phosphorylation at the GS domain
and some represent phosphorylation of other sites. The GS
domain is contained on a single tryptic phosphopeptide; how-
ever, di¡erent phosphoisomers would have di¡erent mobilities
under these conditions. Given the reduced amount of phos-
phorylation of ALK4-5A, clear tryptic phosphopeptide maps
have not been generated for that receptor; however, the in-
crease in overall phosphorylation in response to activin treat-
ment is consistent with the interpretation that ligand-regulated
phosphorylation occurs at non-GS domain sites.
Taken together, the following observations support the no-
tion that phosphorylation of activin type I receptor must oc-
cur at both the GS domain and additional residues to achieve
full activation. (1) ALK4-5A, which cannot be phosphoryl-
ated at the GS domain, can support activin signaling in the
presence of a su⁄cient amount of type II receptor. (2) Acidic
substitution of key residues in the GS domain can apparently
mimic phosphorylation at those sites, but is insu⁄cient to
generate a constitutively active receptor. (3) Analysis of
ALK4 and ALK4-5A phosphorylation indicates the presence
of several activin-inducible sites of phosphorylation. It has
been suggested that phosphorylation of residues in the juxta-
membrane domain of TLRI a¡ects TGFL signaling [11,12].
Mutation of the cognate residues in ALK4 (S168 and S174)
to alanine had no e¡ect on ALK4 activity (not shown). Iden-
ti¢cation of the other sites of ALK4 phosphorylation and
determination of their functional signi¢cance are under way.
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ing phosphoamino acids were resolved in two dimensions by thin-layer electrophoresis (10). (C) Tryptic phosphopeptide maps of ALK4. Phos-
phorylated ALK4 bands, with and without activin treatment as indicated, were excised from the PVDF membrane, digested with trypsin and
eluted from the ¢lter, and the resulting phosphoamino acids were resolved in two dimensions by thin-layer electrophoresis [10]. C: Tryptic
phosphopeptide maps of ALK4. Phosphorylated ALK4 bands, with and without activin treatment as indicated, were excised from the PVDF
membrane, digested with trypsin and eluted from the ¢lter, and the phosphopeptides were resolved by thin-layer electrophoresis in the ¢rst di-
mension and ascending chromatography in the second dimension. The right panel represents a schematic of the patterns; open and ¢lled spots
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